We used Dual-Luciferase Reporter Assay to examine the activation of NF-κB signaling, and we found that the promoter activation of NF-κB was significantly suppressed in RA-FLS-TRIP group compared with control group (Figure 4(a)). The gene discussed is NFKB1; the disease is rheumatoid arthritis.